Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations.

ABSTRACT: Candida albicans, an opportunistic pathogen, is the most common type of fungus and represents a substantial source of human invasive disease (nosocomial infection). This category of fungi are part of our microbiota, and given the appropriate environmental conditions, it has the potential to cause both superficial and systemic infections. There is a soaring resistance against the available anticandidal agents. The purpose of this research is to investigate the activity of certain previously synthesized benzo[g]quinazolines against C. albicans in vitro by using the cup-plate diffusion method. There was a marked difference in the effectiveness of the target compounds 1-6 against the sample of C. albicans that was tested. Benzo[g]quinazolines 1

SUBMITTER: Abuelizz HA 

PROVIDER: S-EPMC10203769 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature